Literature DB >> 30892442

An immunohistochemistry and histopathological study of ankaferd blood stopper in a rat model of cervical inflammation.

Fatma Beyazit1, Basak Buyuk2.   

Abstract

OBJECTIVE: Ankaferd Blood Stopper (ABS) is a medicinal plant extract used topically as a hemostatic, anti-inflammatory, and anti-oxidant agent. Its cytoprotective effect mainly depends on its pleiotropic properties by modulating inflammatory mediators such as IL-1β, IL-6, and TNF-α. This study aims to test the possible therapeutic effect of ABS in the treatment of erosive and inflammatory conditions occurring in the uterine cervix.
METHODS: Twenty-four female Wistar Albino rats were used in the present study. Trichloracetic acid was applied intravaginally to establish an experimental rat model of cervicitis. The rats were randomly divided into three groups: group I (injury), group II (injury+isotoinc saline), and group III (injury+ABS). After 3 estrous cycles of ABS and isotonic saline treatment, the amount of inflammation, vascular congestion and erosion were evaluated in the cervical tissues by using a modified semi-quantitative scale of 0-3. Immunohistochemical staining with monoclonal antibodies against IL-1β was also performed.
RESULTS: Compared with group I and II, the ABS group showed the least inflammatory cell infiltration, vascular congestion and cervical erosion, compared with the ABS group prominent IL-1β staining observed in group I and group II.
CONCLUSION: Our data suggest that ABS is a highly effective alternative to induce normal cervical epithelium and can be used safely in the treatment of cervical inflammation with or without cervical erosion.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 30892442     DOI: 10.1590/1806-9282.65.2.183

Source DB:  PubMed          Journal:  Rev Assoc Med Bras (1992)        ISSN: 0104-4230            Impact factor:   1.209


  2 in total

1.  Histopathological and mechanical effects of Ankaferd Blood Stopper® on wound healing in rats: an experimental model

Authors:  Sertaç Hancioğlu; Berat Dilek Demirel; Ünal Biçakci; Seda Gün; Ender Aritürk; Nurşen Aritürk
Journal:  Turk J Med Sci       Date:  2020-08-26       Impact factor: 0.973

2.  To explore the therapeutic effect of Kangfuxiaomi shuan II on cervicitis in rats.

Authors:  Xiao-Mei Duan; Yu-Sheng Xu; Xiu-Qin Li; Xiu-Ying Ma; Jian-Ting Zhao; Gui-Ke Li; Heng Liu
Journal:  Acta Cir Bras       Date:  2021-11-29       Impact factor: 1.388

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.